These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15461752)

  • 41. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent hemodialysis in children.
    Warady BA; Fischbach M; Geary D; Goldstein SL
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):297-303. PubMed ID: 17603985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dry weight: sine qua non of adequate dialysis.
    Wystrychowski G; Levin NW
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e10-6. PubMed ID: 17603970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anaphylaxis during hemodialysis.
    Hurley RM
    Int J Pediatr Nephrol; 1984 Mar; 5(1):53-4. PubMed ID: 6715114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.
    Rostoker G; Griuncelli M; Loridon C; Benmaadi A; Illouz E
    Cardiology; 2009; 114(2):142-9. PubMed ID: 19521079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug dosing considerations in alternative hemodialysis.
    Decker BS; Mueller BA; Sowinski KM
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e17-26. PubMed ID: 17603971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The link between dialysate and chronic inflammatory disease in hemodialysis.
    Amato RL
    Nephrol Nurs J; 2002 Oct; 29(5):490-2. PubMed ID: 12434456
    [No Abstract]   [Full Text] [Related]  

  • 51. Massive renal and adrenal calcifications in a young dialysis patient with familial Mediterranean fever.
    Delanaye P; Krzesinski JM
    Nephrol Dial Transplant; 2005 Jan; 20(1):238. PubMed ID: 15632359
    [No Abstract]   [Full Text] [Related]  

  • 52. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
    Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
    J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
    Gubensek J; Buturovic-Ponikvar J; Ponikvar R
    Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A crossover study of short daily haemodialysis.
    Goldfarb-Rumyantzev AS; Leypoldt JK; Nelson N; Kutner NG; Cheung AK
    Nephrol Dial Transplant; 2006 Jan; 21(1):166-75. PubMed ID: 16169869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case report of osteomyelitis pubis in a hemodialysis patient with diabetes mellitus.
    Dovas S; Liakopoulos V; Simopoulou T; Giannopoulou M; Kanaki A; Anifandis G; Stefanidis I
    Ther Apher Dial; 2008 Oct; 12(5):409-12. PubMed ID: 18937727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.